The Company's lead product, the CH 2000 Alternans System, is designed to perform a broad range of standard cardiac stress tests, as well as to measure T-wave alternans. The Company sells its products primarily to hospitals, research institutions and cardiovascular specialists.
Revenues reflect decreased sales of standard stress systems.
Lower loss reflects decreased research and development expenses due to lower levels of clinical and regulatory activity. Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Data and information is provided for informational purposes only, and is not intended for trading purposes.